ACCOUNT

SECTIONS

HOME
- Homepage
- This Just In
- Chats
- Weather
- Traffic
- Event Guide
- PG Store
- PGe
- Video
- Photos
- The Digs
- RSS Feeds
NEWS
- News Home
- COVID-19
- World
- Nation
- State
- Obituaries
- News Obituaries
- Politics
- Education
- Portfolio
- Science
- Health & Wellness
- Environment
- Aging Edge
- Transportation
- Faith & Religion
- Crimes & Courts
- Social Services
LOCAL
- Local Home
- Region
- City
- North
- East
- West
- South
- Washington
- Westmoreland
- The Neighborhood
- Obituaries
- Classifieds
- Legal Notices
- Real Estate
SPORTS
- Sports Home
- Steelers
- Penguins
- Pirates
- Sports Columns
- Gene Collier
- Ron Cook
- Joe Starkey
- Paul Zeise
- High School Sports
- College Sports
- Pitt
- Penn State
- WVU
- NCAA
- NFL
- MLB
- NBA
- NHL
- North Shore Drive Podcast
OPINION
A&E
- A&E Home
- Celebrities
- Movies
- TV & Radio
- Music
- Concert Listings
- Theatre & Dance
- Art & Architecture
- Books
- Events
LIFE
- Life Home
- Food
- Buying Here
- Homes & Gardens
- Style & Fashion
- Travel
- Restaurants
- Seen
- goodness
- Random Acts of Kindness
- Pets
- Beer Me
- Outdoors
- Holidays
BUSINESS

OTHER

CLASSIFIEDS

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

BioLife Solutions, Inc. - Common Stock (NQ:BLFS)

19.97 +0.11 (+0.55%)

Streaming Delayed Price Updated: 9:51 AM EDT, Mar 26, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	16,517
Open	19.51
Bid (Size)	19.70 (100)
Ask (Size)	20.24 (300)
Prev. Close	19.86
Today's Range	19.51 - 19.97
52wk Range	17.86 - 29.62
Shares Outstanding	48,300,000
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Relay Therapeutics Stock Up 235% This Past Year as One Fund Lifts Bet to $110 Million ↗

February 27, 2026

Relay Therapeutics develops precision medicines targeting oncology and genetic diseases, leveraging proprietary computational technology.

Via The Motley Fool

Structure Therapeutics Stock Surges 200% This Past Year as One Fund Cuts Stake by $15.5 Million ↗

February 27, 2026

This clinical-stage biotech develops oral therapies for chronic diseases, with a lead candidate targeting type-2 diabetes and obesity.

Via The Motley Fool

Performance

YTD	-16.4%	-16.4%
1 Month	-12.7%	-12.7%
3 Month	-21.4%	-21.4%
6 Month	-17.2%	-17.2%
1 Year	-22.7%	-22.7%

More News

BioLife Solutions Inc (NASDAQ:BLFS) Surpasses Q4 2025 Estimates with Surprise Profit, Stock Rises ↗

February 26, 2026

Via Chartmill

BioLife (BLFS) Q4 2025 Earnings Call Transcript ↗

February 26, 2026

Via The Motley Fool

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

Earnings Scheduled For August 7, 2025 ↗

August 07, 2025

Via Benzinga

Earnings Scheduled For May 8, 2025 ↗

May 08, 2025

Via Benzinga

Exploring BioLife Solns's Earnings Expectations ↗

May 07, 2025

Via Benzinga

BioLife Solutions' CFO Sells 30,000 Shares ↗

December 11, 2025

Via The Motley Fool

BioLife (BLFS) Q3 2025 Earnings Call Transcript ↗

November 09, 2025

Via The Motley Fool

BioLife Solutions Inc (NASDAQ:BLFS) Beats Q3 2025 Earnings and Revenue Estimates ↗

November 06, 2025

Via Chartmill

BioLife Solutions Inc (NASDAQ:BLFS) Reports Mixed Q2 2025 Results with Revenue Beat but Profitability Concerns ↗

August 07, 2025

Via Chartmill

Earnings Scheduled For March 3, 2025 ↗

March 03, 2025

Via Benzinga

Analyst Expectations For BioLife Solns's Future ↗

November 18, 2024

Via Benzinga

Earnings Scheduled For November 12, 2024 ↗

November 12, 2024

Via Benzinga

Key Takeaways From BioLife Solns Analyst Ratings ↗

September 30, 2024

Via Benzinga

BLFS Stock Earnings: BioLife Solns Beats EPS, Beats Revenue for Q2 2024 ↗

August 08, 2024

Via InvestorPlace

BLFS Stock Earnings: BioLife Solns Beats EPS, Beats Revenue for Q1 2024 ↗

May 09, 2024

Via InvestorPlace

Meta Platforms, Pure Storage And 2 Other Stocks Insiders Are Selling ↗

April 19, 2024

Via Benzinga

Recap: BioLife Solns Q4 Earnings ↗

February 29, 2024

Via Benzinga

Earnings Scheduled For February 29, 2024 ↗

February 29, 2024

Via Benzinga

Earnings Preview For BioLife Solns ↗

February 28, 2024

Via Benzinga

BioLife Solns: Q3 Earnings Insights ↗

November 09, 2023

Via Benzinga

Over $1M Bet On Carnival? Check Out These 3 Stocks Insiders Are Buying ↗

October 24, 2023

Via Benzinga

Top 5 Health Care Stocks That Could Blast Off This Month ↗

August 21, 2023

Via Benzinga

Frequently Asked Questions

Is BioLife Solutions, Inc. - Common Stock publicly traded?

Yes, BioLife Solutions, Inc. - Common Stock is publicly traded.

What exchange does BioLife Solutions, Inc. - Common Stock trade on?

BioLife Solutions, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for BioLife Solutions, Inc. - Common Stock?

The ticker symbol for BioLife Solutions, Inc. - Common Stock is BLFS on the Nasdaq Stock Market

What is the current price of BioLife Solutions, Inc. - Common Stock?

The current price of BioLife Solutions, Inc. - Common Stock is 19.97

When was BioLife Solutions, Inc. - Common Stock last traded?

The last trade of BioLife Solutions, Inc. - Common Stock was at 03/26/26 09:51 AM ET

What is the market capitalization of BioLife Solutions, Inc. - Common Stock?

The market capitalization of BioLife Solutions, Inc. - Common Stock is 964.55M

How many shares of BioLife Solutions, Inc. - Common Stock are outstanding?

BioLife Solutions, Inc. - Common Stock has 965M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.